This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nam, S.-Y. Articles by Marcus, C. Search for Related Content PubMed PubMed Citation Articles by Nam, S.-Y. Articles by Marcus, C.

Cerebrospinal Fluid and Plasma Concentrations of Leptin, NPY, and -MSH in Obese Women and Their Relationship to Negative Energy Balance

Division of Endocrinology, Department of Internal Medicine (S.-Y.N., K.W.K., K.R.K., S.-K.L.), Yonsei University, College of Medicine, 135-170 Seoul, Korea; Institute of Clinical Chemistry (J.K.), University of Leipzig, 04103 Leipzig, Germany; and Department of Pediatrics, Endocrine Unit (C.M.), Huddinge Hospital, Karolinska Institute, Sweden

Address all correspondence and requests for reprints to: Su Youn Nam, M.D., Ph.D., Division of Endocrinology, Department of Internal Medicine, Yong Dong Severance Hospital, Yonsei University College of Medicine, Young Dong P.O. Box 1217, Seoul, Korea. E-mail: suyoun{at}hotmail.com

Abstract

Leptin and its principal mediators, NPY and -MSH are postulated to play a pivotal role in energy balance. To determine the possibility of the disturbance in neuropeptides in human obesity and their consequent changes in response to negative energy balance, we evaluated plasma and cerebrospinal fluid (CSF) leptin, NPY, and -MSH levels in obese women before and after weight loss in comparison with normal control women. Subjects included 16 obese women [mean body mass index (BMI), 35.6 kg/m²] before and after weight loss induced by a 2-wk very low caloric diet (800 kcal/d) and 14 normal weight women (mean BMI, 20.4 kg/m²). The CSF to plasma leptin ratio in normal weight subjects was 2.3-fold higher than that in obese subjects. After weight loss in obese subjects, plasma leptin levels decreased by 40% and CSF levels decreased by 51%. There was a positive linear correlation between CSF and plasma leptin levels at baseline in obese subjects (r = 0.74, P < 0.05) and a positive logarithmic correlation in normal weight subjects (r = 0.89, P < 0.05) and in obese subjects after weight loss (r = 0.64, P < 0.05). The BMI was negatively correlated with the CSF to plasma leptin ratio (r = -0.86, P < 0.05) in all subjects. Neither the baseline plasma levels nor the baseline CSF levels of NPY were different between normal weight subjects and obese subjects. After weight loss, the CSF NPY level decreased significantly compared with baseline values in obese subjects. The -MSH levels in plasma and CSF did not differ significantly from controls in obese subjects at baseline or after weight loss. Baseline CSF leptin level correlated with neither the baseline CSF NPY level nor the baseline CSF -MSH level.

In conclusion, this study demonstrated that the efficiency of brain leptin delivery is reduced in human obesity and central nervous system leptin uptake involves a combination of a saturable and an unsaturable mechanism. CSF NPY and -MSH did not differ from controls in human obesity, and the CSF NPY level decreased significantly whereas -MSH did not differ after weight loss in obese subjects compared with baseline. There was no significant correlation between CSF leptin and CSF NPY or -MSH. This could be the result of leptin resistance present in human obesity and/or the more complex mechanisms involved in modulating appetite and regulating energy balance in human obesity.

This article has been cited by other articles:

				K. Kos, A. L. Harte, N. F. da Silva, A. Tonchev, G. Chaldakov, S. James, D. R. Snead, B. Hoggart, J. P. O'Hare, P. G. McTernan, et al. Adiponectin and Resistin in Human Cerebrospinal Fluid and Expression of Adiponectin Receptors in the Human Hypothalamus J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1129 - 1136. [Abstract] [Full Text] [PDF]

				Y.-W. Kim, J.-Y. Kim, Y.-H. Park, S.-Y. Park, K.-C. Won, K.-H. Choi, J.-Y. Huh, and K.-H. Moon Metformin Restores Leptin Sensitivity in High-Fat-Fed Obese Rats With Leptin Resistance Diabetes, March 1, 2006; 55(3): 716 - 724. [Abstract] [Full Text] [PDF]

				K. Aydin, A. Serdaroglu, C. Okuyaz, A. Bideci, and K. Gucuyener Serum Insulin, Leptin, and Neuropeptide Y Levels in Epileptic Children Treated With Valproate J Child Neurol, October 1, 2005; 20(10): 848 - 851. [Abstract] [PDF]

				A. Gavrila, J. L. Chan, L. C. Miller, K. Heist, N. Yiannakouris, and C. S. Mantzoros Circulating Melanin-Concentrating Hormone, Agouti-Related Protein, and {alpha}-Melanocyte-Stimulating Hormone Levels in Relation to Body Composition: Alterations in Response to Food Deprivation and Recombinant Human Leptin Administration J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1047 - 1054. [Abstract] [Full Text] [PDF]

				M. Hallschmid, C. Benedict, B. Schultes, H.-L. Fehm, J. Born, and W. Kern Intranasal Insulin Reduces Body Fat in Men but not in Women Diabetes, November 1, 2004; 53(11): 3024 - 3029. [Abstract] [Full Text] [PDF]

				J. Cornish, K. E. Callon, K. G. Mountjoy, U. Bava, J.-M. Lin, D. E. Myers, D. Naot, and I. R. Reid alpha -Melanocyte-stimulating hormone is a novel regulator of bone Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1181 - E1190. [Abstract] [Full Text] [PDF]

				N. Lahlou, T. Issad, Y. Lebouc, J.-C. Carel, L. Camoin, M. Roger, and J. Girard Mutations in the Human Leptin and Leptin Receptor Genes as Models of Serum Leptin Receptor Regulation Diabetes, June 1, 2002; 51(6): 1980 - 1985. [Abstract] [Full Text] [PDF]